• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

.

.

机构信息

Department of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore 117543, Singapore.

NUS Graduate School of Integrative Sciences and Engineering, National University of Singapore, 21 Lower Kent Ridge Rd, Singapore 119077, Singapore.

出版信息

Inorg Chem. 2021 Feb 1;60(3):1823-1831. doi: 10.1021/acs.inorgchem.0c03299. Epub 2021 Jan 19.

DOI:10.1021/acs.inorgchem.0c03299
PMID:33464875
Abstract

A common challenge in Pt(IV) prodrug design is the limited repertoire of linkers available to connect the Pt(IV) scaffold with the bioactive payload. The commonly employed linkers are either too stable, leading to a linker artifact on the payload upon release, or too unstable, leading to premature release. In this study, we report the synthesis of a new class of Pt(IV) prodrugs using masked self-immolative 4-aminobenzyl linkers for controlled and traceless codrug delivery. Upon reduction of self-immolative Pt(IV) prodrugs, the detached axial ligands undergo decarboxylation and 1,6-elimination for payload release. Introduction of self-immolative linkers conferred good aqueous stability to the Pt(IV) codrug complex. Investigation revealed that efficient 1,6-elimination could be attributed to stabilization of the aza-quinone-methide intermediate. In particular, the self-immolative Pt(IV) prodrugs with cinnamate and coumarin derivatives were more potent than the coadministration of cisplatin with an unconjugated cinnamate or coumarin payload in vitro.

摘要

在 Pt(IV)前药设计中,将 Pt(IV)支架与生物活性有效载荷连接的连接子的选择有限,这是一个常见的挑战。常用的连接子要么太稳定,导致有效载荷在释放时出现连接子副产物,要么太不稳定,导致过早释放。在这项研究中,我们报告了使用掩蔽的自毁 4-氨基苄基连接子合成新型 Pt(IV)前药,用于控制和无痕共药传递。自毁性 Pt(IV)前药还原后,脱落的轴向配体发生脱羧和 1,6-消除,释放有效载荷。引入自毁性连接子可提高 Pt(IV)共药复合物的水稳定性。研究表明,有效的 1,6-消除可归因于氮杂醌甲亚胺中间体的稳定化。特别是,肉桂酸酯和香豆素衍生物的自毁性 Pt(IV)前药在体外比顺铂与未缀合的肉桂酸酯或香豆素有效载荷的联合给药更有效。

相似文献

1
..
Inorg Chem. 2021 Feb 1;60(3):1823-1831. doi: 10.1021/acs.inorgchem.0c03299. Epub 2021 Jan 19.
2
Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs?Pt(IV) 前药是真正的多作用前药吗?能释放 combretastatin A4
J Med Chem. 2021 Aug 12;64(15):11364-11378. doi: 10.1021/acs.jmedchem.1c00706. Epub 2021 Aug 3.
3
Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon.铂(IV)前药共轭超分子六边形的配位驱动自组装
Chem Commun (Camb). 2018 Jan 18;54(7):731-734. doi: 10.1039/c7cc07622c.
4
Functionalized nonporous silica nanoparticles as carriers for Pt(iv) anticancer prodrugs.功能化无孔二氧化硅纳米颗粒作为铂(IV)抗癌前药的载体
Dalton Trans. 2016 Nov 1;45(43):17233-17240. doi: 10.1039/c6dt03133a.
5
Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.奥沙利铂与大黄酸和阿魏酸的配合物作为具有高抗肿瘤活性的铂(IV)前药。
Dalton Trans. 2020 Feb 7;49(5):1613-1619. doi: 10.1039/c9dt04594e. Epub 2020 Jan 16.
6
Alternative mechanism of action of the DNP Pt prodrug: intracellular cisplatin release and the mitochondria-mediated apoptotic pathway.DNP Pt 前药的另一种作用机制:细胞内顺铂释放和线粒体介导的细胞凋亡途径。
Dalton Trans. 2021 Jun 15;50(23):7922-7927. doi: 10.1039/d1dt00898f.
7
Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood.工程化胆固醇键合两亲性 Pt(iv)前药的脂质体纳米粒,延长其在血液中的循环时间。
Dalton Trans. 2020 Jun 23;49(24):8107-8113. doi: 10.1039/d0dt01297a.
8
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs.功能性荧光无孔二氧化硅纳米颗粒作为铂(IV)抗癌前药的载体
J Inorg Biochem. 2015 Oct;151:132-42. doi: 10.1016/j.jinorgbio.2015.08.001. Epub 2015 Aug 6.
9
A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy.一种双靶向混合铂(IV)前药,可提高疗效。
Chem Commun (Camb). 2012 Nov 11;48(87):10730-2. doi: 10.1039/c2cc34297a.
10
A Pt(IV) Prodrug Combining Chlorambucil and Cisplatin: a Dual-Acting Weapon for Targeting DNA in Cancer Cells.铂(IV)前药结合苯丁酸氮芥和顺铂:一种针对癌细胞 DNA 的双重作用武器。
Int J Mol Sci. 2018 Nov 27;19(12):3775. doi: 10.3390/ijms19123775.

引用本文的文献

1
Oxali(IV)Fluors: Fluorescence Responsive Oxaliplatin(IV) Complexes Identify a Hypoxia-Dependent Reduction in Cancer Cells.奥沙利铂(IV)氟化物:荧光响应性奥沙利铂(IV)配合物可识别癌细胞中缺氧相关的减少。
J Am Chem Soc. 2023 Jun 21;145(24):12998-13002. doi: 10.1021/jacs.3c03320. Epub 2023 Jun 7.
2
Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands.脂肪酸代谢对以苯丁酸盐为轴向配体的顺铂(IV)配合物作用模式的影响。
Pharmaceutics. 2023 Feb 16;15(2):677. doi: 10.3390/pharmaceutics15020677.
3
Synthesis and anticancer activity of two highly water-soluble and ionic Pt(iv) complexes as prodrugs for Pt(ii) anticancer drugs.
两种高水溶性离子型Pt(IV)配合物作为Pt(II)抗癌药物前药的合成及抗癌活性
RSC Med Chem. 2022 Mar 18;13(5):594-598. doi: 10.1039/d2md00004k. eCollection 2022 May 25.